Hematologic Oncology | Specialty

The OncLive Hematology Oncology condition center page is a comprehensive resource for clinical news and expert insights on various hematologic malignancies, including leukemias, lymphomas, myeloproliferative neoplasms, multiple myeloma, and much more. This section features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in hematologic cancers.

Comorbidities and Role of R-CHOP in DLBCL

January 30th 2020

Prognostic Factors in DLBCL

January 30th 2020

Treatment of Newly Diagnosed DLBCL

January 30th 2020

Final Thoughts From ASH 2019 on MDS

January 30th 2020

Emerging Agents in Development for MDS

January 30th 2020

Phase III MEDALIST Trial of Luspatercept for MDS

January 30th 2020

Lenalidomide in Del 5q MDS

January 30th 2020

Erythropoiesis-Stimulating Agents for Lower-Risk MDS

January 30th 2020

MDS: Low-Risk Disease Treatment Options

January 30th 2020

Iron Chelation Therapy for MDS

January 30th 2020

Thresholds for Blood Transfusions for MDS

January 30th 2020

Re-Staging Patients with MDS

January 30th 2020

Factoring in Comorbidities in MDS Risk Stratification

January 30th 2020

The Use of Molecular Testing in MDS

January 30th 2020

Risk Stratification in MDS

January 30th 2020

Clinical Presentation and Symptoms of MDS

January 30th 2020

Diagnosis of Myelodysplastic Syndrome

January 30th 2020

Expert Calls Attention to Treatment-Emergent AEs in Follicular Lymphoma

January 29th 2020

Lawrence D. Kaplan, MD, discusses standard frontline treatment in follicular lymphoma, toxicities of some of the newer agents, and preliminary data with bispecific antibodies.

Brentuximab Vedotin Leads Treatment Progress in Hodgkin Lymphoma

January 28th 2020

Syed Rizvi, MD, discusses recent therapeutic advances in advanced-stage Hodgkin lymphoma.

Targeted Therapy Shifts AML Paradigm, But More Work Lies Ahead

January 28th 2020

Prapti Patel, MD, discusses available and emerging treatment options for patients with acute myeloid leukemia.